Premium
Outcomes of fertility‐sparing surgery for women of reproductive age with FIGO stage IC epithelial ovarian cancer
Author(s) -
Kashima Katsunori,
Yahata Tetsuro,
Fujita Kazuyuki,
Tanaka Kenichi
Publication year - 2013
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/j.ijgo.2012.10.027
Subject(s) - medicine , stage (stratigraphy) , serous fluid , ovary , gynecology , ovarian cancer , fertility , serous carcinoma , retrospective cohort study , pregnancy , cancer , obstetrics , surgery , population , paleontology , environmental health , biology , genetics
Objective To report the clinical outcomes of patients with FIGO stage IC epithelial ovarian cancer (EOC) treated by fertility‐sparing surgery (FSS). Methods A retrospective review was conducted of 18 women who underwent FSS at Niigata University Hospital, Japan, between December 15, 1986, and December 31, 2010. Results Tumors were mucinous (n = 9), clear cell (n = 4), endometrioid (n = 3), and serous (n = 2). Median follow‐up was 78.0 months (range, 9.3–181.3 months). Five patients (27.8%) developed tumor recurrence at 7.4–19.2 months after initial surgery. The sites of recurrence were peritoneal lymph nodes (n = 2), contralateral ovary (n = 1), contralateral ovary and peritoneal cavity (n = 1), and brain (n = 1). In all, 7 full‐term singleton pregnancies were recorded among 5 of the 10 women who attempted to conceive after FSS. Conclusion Favorable reproductive outcomes were observed following FSS, suggesting that this procedure may be a valid treatment option for women with FIGO stage IC EOC who wish to conceive.